| Scott Jonathan Haarburger, DO | |
|
1 Plainsboro Rd, Plainsboro, NJ 08536-1913 | |
| (609) 853-6049 | |
| (609) 853-7221 |
| Full Name | Scott Jonathan Haarburger |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 6 Years |
| Location | 1 Plainsboro Rd, Plainsboro, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811490766 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | OS021783 (Pennsylvania) | Secondary |
| 207R00000X | Internal Medicine | 25MB10997200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center Of Princeton At Plainsboro | Plainsboro, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Health Care Associates Of New Jersey Pc | 0749180198 | 664 |
| First Docs Llc | 1254751456 | 23 |
News Archive
INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes.
Gastric and colorectal cancers account for more than 1 million deaths worldwide every year and several research groups have been working to identify the molecular events that result in the initiation and progression of these tumors.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.
› Verified 3 days ago
| Entity Name | Geps Physician Group Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871512038 PECOS PAC ID: 4981590346 Enrollment ID: O20040409000423 |
News Archive
INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes.
Gastric and colorectal cancers account for more than 1 million deaths worldwide every year and several research groups have been working to identify the molecular events that result in the initiation and progression of these tumors.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.
› Verified 3 days ago
| Entity Name | Clinical Health Care Associates Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447260435 PECOS PAC ID: 0749180198 Enrollment ID: O20040421001473 |
News Archive
INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes.
Gastric and colorectal cancers account for more than 1 million deaths worldwide every year and several research groups have been working to identify the molecular events that result in the initiation and progression of these tumors.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.
› Verified 3 days ago
| Entity Name | Gps Physician Group Of New Jersey, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548776008 PECOS PAC ID: 4688933674 Enrollment ID: O20180119002091 |
News Archive
INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes.
Gastric and colorectal cancers account for more than 1 million deaths worldwide every year and several research groups have been working to identify the molecular events that result in the initiation and progression of these tumors.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.
› Verified 3 days ago
| Entity Name | First Docs Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154936227 PECOS PAC ID: 1254751456 Enrollment ID: O20210505003195 |
News Archive
INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes.
Gastric and colorectal cancers account for more than 1 million deaths worldwide every year and several research groups have been working to identify the molecular events that result in the initiation and progression of these tumors.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Jonathan Haarburger, DO 1 Plainsboro Rd, Plainsboro, NJ 08536-1913 Ph: (609) 853-6049 | Scott Jonathan Haarburger, DO 1 Plainsboro Rd, Plainsboro, NJ 08536-1913 Ph: (609) 853-6049 |
News Archive
INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes.
Gastric and colorectal cancers account for more than 1 million deaths worldwide every year and several research groups have been working to identify the molecular events that result in the initiation and progression of these tumors.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.
› Verified 3 days ago
Catherine Chen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Plainsboro Rd, Plainsboro, NJ 08536 Phone: 609-853-6049 Fax: 609-853-7221 | |
Arjun Fung-janardhan, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Plainsboro Rd, Plainsboro, NJ 08536 Phone: 609-853-6049 | |
Mrs. Silky Sharma, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Plainsboro Rd, Plainsboro, NJ 08536 Phone: 609-853-5600 | |
Dr. Ahmed Mirza, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 666 Plainsboro Rd, Suite 1318, Plainsboro, NJ 08536 Phone: 732-266-3733 | |
Dr. Lloyd Antoine Webster Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Plainsboro Rd, Plainsboro, NJ 08536 Phone: 609-853-6049 Fax: 609-853-7221 | |
Dr. Ramy Sedhom, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 Plainsboro Rd Ste 540, Plainsboro, NJ 08536 Phone: 609-853-6590 Fax: 609-853-6581 | |
Dr. Matthew Sandel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 Plainsboro Rd Ste 350, Plainsboro, NJ 08536 Phone: 609-853-6049 Fax: 609-853-7221 |